DrugDashboards

Risedronate Sodium

Risedronate Sodium · RISEDRONATE SODIUM HEMI-PENTAHYDRATE 35 mg/1 · Tablet, Film Coated · Oral · Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd

NDC 60723-0041-04 · 1 BLISTER PACK in 1 CARTON / 4 TABLET, FILM COATED in 1 BLISTER PACK · ANDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. One of its named manufacturing plants, Hangzhou Minsheng Binjiang Pharmaceutical Co.,Ltd, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for risedronate sodium (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA207516
TE code
—
Approval date
Feb 15, 2019
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Risedronate Sodium (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedRISEDRONATE SODIUM 5 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedRISEDRONATE SODIUM 35 mg/1Jul 15, 2026Sep 3, 2026
Allergan, Inc.RISEDRONATE SODIUM HEMIPENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1Jul 15, 2026Sep 2, 2026
Allergan, Inc.RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1Jul 15, 2026Sep 2, 2026
Allergan, Inc.RISEDRONATE SODIUM HEMIPENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1Jul 15, 2026Sep 2, 2026
Allergan, Inc.RISEDRONATE SODIUM HEMI-PENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.RISEDRONATE SODIUM 75 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.RISEDRONATE SODIUM 150 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.RISEDRONATE SODIUM 35 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedRISEDRONATE SODIUM 150 mg/1Jul 15, 2026Sep 2, 2026
Hangzhou Minsheng Binjiang Pharmaceutical CO., LtdRISEDRONATE SODIUM HEMI-PENTAHYDRATE 35 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedRISEDRONATE SODIUM 30 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedRISEDRONATE SODIUM 35 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedRISEDRONATE SODIUM 5 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals, Inc.RISEDRONATE SODIUM HEMIPENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals, Inc.RISEDRONATE SODIUM HEMIPENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1Jul 15, 2026Sep 2, 2026
Pel Healthcare LlcRISEDRONATE SODIUM MONOHYDRATE 150 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPRISEDRONATE SODIUM 35 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.RISEDRONATE SODIUM HEMI-PENTAHYDRATE 150 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.RISEDRONATE SODIUM HEMI-PENTAHYDRATE 35 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.RISEDRONATE SODIUM HEMI-PENTAHYDRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.RISEDRONATE SODIUM HEMI-PENTAHYDRATE 75 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.RISEDRONATE SODIUM MONOHYDRATE 30 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.RISEDRONATE SODIUM MONOHYDRATE 35 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.RISEDRONATE SODIUM MONOHYDRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedRISEDRONATE SODIUM 30 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Risedronate Sodium — NDC 60723-0041-04," retrieved September 3, 2026, https://drugdashboards.com/drug/60723004104.

Free to cite with attribution — see how the data is put together.